TipRanks
SK bioscience Co.,Ltd. (KR:302440)
:302440
South Korea Market
302440
SK bioscience Co.,Ltd.
RESEARCH TOOLSreports

SK bioscience Co.,Ltd. (302440) Ratios

― Followers

SK bioscience Co.,Ltd. Ratios

KR:302440's free cash flow for Q2 2026 was ₩0.23. For the 2026 fiscal year, KR:302440's free cash flow was decreased by ₩ and operating cash flow was ₩-0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.60 3.82 5.08 10.20 4.69
Quick Ratio
 2.95 3.24 4.40 9.60 4.20
Cash Ratio
 0.39 0.32 1.01 0.94 0.59
Solvency Ratio
 0.02 0.04 >-0.01 0.38 0.37
Operating Cash Flow Ratio
 <0.01 0.31 -0.41 0.22 -0.33
Short-Term Operating Cash Flow Coverage
 0.07 27.31 -18.40 0.00 -1.50
Net Current Asset Value
₩ 227.78B₩ 327.84B₩ 755.53B₩ 1.23T₩ 1.38T
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.16 0.14 0.01 0.05
Debt-to-Equity Ratio
 0.31 0.26 0.22 0.01 0.07
Debt-to-Capital Ratio
 0.24 0.21 0.18 0.01 0.06
Long-Term Debt-to-Capital Ratio
 0.23 0.21 0.18 0.00 0.00
Financial Leverage Ratio
 1.71 1.65 1.58 1.09 1.23
Debt Service Coverage Ratio
 -4.13 -2.33 0.26 41.83 1.77
Interest Coverage Ratio
 -12.37 -16.10 -37.57 -3.38 46.74
Debt to Market Cap
 0.19 0.12 0.10 0.00 0.01
Interest Debt Per Share
 7.09K 6.13K 5.14K 286.49 1.51K
Net Debt to EBITDA
 -3.29 -6.04 -2.21 -2.45 -0.65
Profitability Margins
Gross Profit Margin
10.13%9.13%11.58%38.38%52.46%
EBIT Margin
-33.96%-23.23%-31.93%2.36%31.57%
EBITDA Margin
-19.06%-9.26%-13.53%11.77%37.53%
Operating Profit Margin
-23.77%-23.23%-51.74%-1.28%25.18%
Pretax Profit Margin
-15.35%-13.18%-33.31%1.98%31.03%
Net Profit Margin
-12.03%-8.62%-20.14%6.04%26.81%
Continuous Operations Profit Margin
-12.98%-8.62%-18.73%6.04%26.81%
Net Income Per EBT
78.42%65.42%60.47%304.59%86.40%
EBT Per EBIT
64.55%56.74%64.37%-154.88%123.23%
Return on Assets (ROA)
-2.66%-1.90%-1.89%1.20%5.72%
Return on Equity (ROE)
-4.45%-3.14%-2.99%1.31%7.03%
Return on Capital Employed (ROCE)
-5.92%-5.75%-5.47%-0.28%6.53%
Return on Invested Capital (ROIC)
-4.98%-3.75%-3.06%-0.27%5.35%
Return on Tangible Assets
-2.92%-2.03%-1.98%1.22%5.77%
Earnings Yield
-2.77%-1.49%-1.38%0.40%2.17%
Efficiency Ratios
Receivables Turnover
 4.69 4.90 1.42 41.41 11.54
Payables Turnover
 14.93 16.77 13.28 67.56 19.64
Inventory Turnover
 2.73 3.13 1.12 2.82 1.16
Fixed Asset Turnover
 0.57 0.58 0.27 1.17 1.56
Asset Turnover
 0.22 0.22 0.09 0.20 0.21
Working Capital Turnover Ratio
 0.73 0.60 0.21 0.28 0.33
Cash Conversion Cycle
 187.31 169.41 555.27 132.70 328.11
Days of Sales Outstanding
 77.84 74.50 257.02 8.82 31.63
Days of Inventory Outstanding
 133.93 116.68 325.74 129.29 315.05
Days of Payables Outstanding
 24.45 21.76 27.49 5.40 18.58
Operating Cycle
 211.77 191.17 582.76 138.11 346.69
Cash Flow Ratios
Operating Cash Flow Per Share
 11.61 1.31K -1.66K 382.65 -1.63K
Free Cash Flow Per Share
 -2.07K -1.03K -3.89K -273.15 -2.63K
CapEx Per Share
 2.08K 2.34K 2.23K 655.80 997.05
Free Cash Flow to Operating Cash Flow
 -178.08 -0.79 2.35 -0.71 1.61
Dividend Paid and CapEx Coverage Ratio
 <0.01 0.56 -0.74 0.58 -1.63
Capital Expenditure Coverage Ratio
 <0.01 0.56 -0.74 0.58 -1.63
Operating Cash Flow Coverage Ratio
 <0.01 0.22 -0.33 1.43 -1.10
Operating Cash Flow to Sales Ratio
 <0.01 0.16 -0.48 0.08 -0.27
Free Cash Flow Yield
-5.67%-2.14%-7.72%-0.37%-3.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -34.23 -67.11 -71.98 251.89 46.05
Price-to-Sales (P/S) Ratio
 4.34 5.79 14.54 15.21 12.35
Price-to-Book (P/B) Ratio
 1.64 2.11 2.16 3.30 3.24
Price-to-Free Cash Flow (P/FCF) Ratio
 -17.65 -46.78 -12.96 -268.35 -27.99
Price-to-Operating Cash Flow Ratio
 3.14K 36.77 -30.39 191.56 -45.12
Price-to-Earnings Growth (PEG) Ratio
 0.04 -25.96 0.21 -3.08 -0.70
Price-to-Fair Value
 1.64 2.11 2.16 3.30 3.24
Enterprise Value Multiple
 -26.08 -68.54 -109.71 126.81 32.24
Enterprise Value
 3.28T 4.13T 3.97T 5.52T 5.53T
EV to EBITDA
 -26.08 -68.54 -109.71 126.81 32.24
EV to Sales
 4.97 6.35 14.84 14.93 12.10
EV to Free Cash Flow
 -20.20 -51.30 -13.23 -263.26 -27.43
EV to Operating Cash Flow
 3.60K 40.33 -31.02 187.93 -44.23
Tangible Book Value Per Share
 22.26K 23.57K 24.58K 21.92K 22.47K
Shareholders’ Equity Per Share
 22.26K 22.87K 23.35K 22.22K 22.70K
Tax and Other Ratios
Effective Tax Rate
 0.15 0.35 0.44 -2.05 0.14
Revenue Per Share
 8.40K 8.33K 3.47K 4.82K 5.95K
Net Income Per Share
 -1.01K -718.26 -697.93 291.00 1.60K
Tax Burden
 0.78 0.65 0.60 3.05 0.86
Interest Burden
 0.45 0.57 1.04 0.84 0.98
Research & Development to Revenue
 0.10 0.15 0.27 0.23 0.13
SG&A to Revenue
 0.10 0.07 0.15 0.07 0.06
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.01 -1.79 2.55 1.31 -1.02
Currency in KRW